What is PT141 ?
PT-141 (Bremelanotide)is a centrally acting melanocortin receptor agonist used to enhancesexual desire and arousalin both men and women. Originally developed to treat sexual dysfunction, it is FDA-approved forhypoactive sexual desire disorder (HSDD) in premenopausal womenand is also commonly used off-label in men withlow libido or erectile dysfunction—especially when psychological or central causes are suspected. Unlike traditional ED medications, PT-141 works through the brain rather than blood flow.